Alivus Life Sciences Limited (NSE:ALIVUS)
India · Delayed Price · Currency is INR 1,159.90
+17.00 (1.49%)
Jul 10, 2026, 3:29 PM IST
Alivus Life Sciences Market Cap
Alivus Life Sciences has a market cap or net worth of 142.39 billion as of July 10, 2026. Its market cap has increased by 16.02% in one year.
Market Cap
142.39B
Enterprise Value
135.13B
Revenue
25.52B
Ranking
n/a
PE Ratio
25.27
Stock Price
1,159.90
Market Cap Chart
Since August 6, 2021, Alivus Life Sciences's market cap has increased from 91.71B to 142.39B, an increase of 55.26%. That is a compound annual growth rate of 9.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 142.39B | 26.63% |
| Dec 31, 2025 | 112.45B | -6.68% |
| Dec 31, 2024 | 120.50B | 49.68% |
| Dec 29, 2023 | 80.51B | 56.38% |
| Dec 30, 2022 | 51.48B | -33.42% |
| Dec 31, 2021 | 77.32B | -15.69% |
| Aug 6, 2021 | 91.71B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Wockhardt | 294.22B |
| Piramal Pharma | 235.12B |
| Eris Lifesciences | 198.32B |
| NATCO Pharma | 176.26B |
| Cohance Lifesciences | 172.88B |
| Alembic Pharmaceuticals | 164.60B |
| Akums Drugs and Pharmaceuticals | 107.47B |
| Strides Pharma Science | 99.79B |